Centessa Pharmaceuticals plc (LON: 0ACX)
London
· Delayed Price · Currency is GBP · Price in USD
16.53
+0.98 (6.33%)
At close: Jan 22, 2025
Centessa Pharmaceuticals Revenue
Centessa Pharmaceuticals had revenue of $6.85M USD in the twelve months ending September 30, 2024. In the year 2023, Centessa Pharmaceuticals had annual revenue of $6.85M.
Revenue
$6.85M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
$90.17K
Employees
76
Market Cap
1.79B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6.85M | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shell | 221.41B |
AstraZeneca | 38.20B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
BP p.l.c. | 144.69B |
British American Tobacco p.l.c. | 26.18B |
Centessa Pharmaceuticals News
- 15 days ago - Centessa Pharmaceuticals names Stephen Kanes as chief medical officer - Seeking Alpha
- 15 days ago - Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer - GlobeNewsWire
- 23 days ago - Centessa Pharmaceuticals: Orexin Franchise Worth Monitoring - Seeking Alpha
- 27 days ago - Centessa: Shift In Focus With ORX750 Development Continues To Pay Off - Seeking Alpha
- 2 months ago - Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update - GlobeNewsWire
- 4 months ago - Centessa Pharmaceuticals Presents Preclinical Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024) - GlobeNewsWire
- 4 months ago - Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares - GlobeNewsWire
- 4 months ago - Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares - GlobeNewsWire